Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2016 KRANKHEITSBILD NETZWERK REGISTRY PROJEKTE ANMELDEN
 
 
  
Wet Biomarkers -
--->Aktuelles
[+]Das Projekt
[-]Standorte
--->[+]Österreich
--->[-]Belgien
--->Koordination
--->Selbsthilfe
--->Antwerpen
--->[+]Bierbeek
--->Brüssel - VUB
--->Brüssel - Saint Luc
--->Bruxelles - ULB
--->Charleroi
--->Leuven
--->Liège (Luik)
--->[+]Tschechische Republik
--->[+]Dänemark
--->[-]Finnland
--->Koordination
--->Selbsthilfe
--->Dates
--->Åland
--->Helsinki-HUH
--->Helsinki-Vaestoliitto
--->Kuopio
--->Oulu
--->Tampere
--->Turku-Suvituuli
--->Turku-TUH
--->[+]Frankreich
--->[+]Deutschland
--->[+]Ireland
--->[-]Italien
--->Koordination
--->Selbsthilfe
--->Bari
--->Bologna
--->Brescia
--->Cagliari
--->Florenz
--->Genua
--->Mailand
--->Neapel
--->Pisa
--->Pozzilli
--->Rom
--->Rm-Mi-Fi LIRH
--->Rome-Sant'Andrea
--->[+]Niederlande
--->[+]Norwegen
--->[+]Polen
--->[+]Portugal
--->[+]Russia
--->[-]Spanien
--->Koordination
--->Selbsthilfe
--->Alicante
--->Badajoz
--->Barcelona - Bellvitge
--->Barcelona - Clinic i Provincia...
--->Barcelona - Mutua de Terra...
--->Barcelona - Santa Creu i Sa...
--->Barcelona - Merced
--->Bilbao
--->Burgos
--->Canaries
--->Granada
--->Fuenlabrada
--->[-]Madrid-BTCIEN
--->[-]Documents
--->Informed Consent
--->ERB
--->Madrid - Clínico
--->Madrid - FJD
--->Madrid - RyC
--->Murcia
--->Oviedo
--->Palma de Mallorca
--->Pamplona
--->Santiago
--->Sevilla
--->Sevilla-HUVRocio
--->Sevilla-St-Ana
--->Valencia
--->Zaragoza
--->[+]Schweden
--->[+]Schweiz
--->[+]U.K.
--->[+]Outside Europe
[-]Arbeitsgruppen
--->[+]Advanced HD
--->[+]Psychiatrischer Phänotyp
--->[-]Biologische Modifizierer
--->Termine
--->[-]Meetings
--->Meeting 2008/04
--->Meeting 2008/09
--->Meeting 2009
--->[+]Biomarker
--->[+]Hirngewebedatenbank
--->[+]Kognitiver Phänotyp
--->[+]Environmental Modifiers
--->[+]Funktionelle Fähigkeit
--->[+]Genetische Tests/Beratung
--->[-]Modifizierende Gene
--->[+]Termine
--->[-]Meetings
--->Meeting 2005/09
--->Meeting 2006/04
--->Meeting 2008/09
--->Meeting 2009/06
--->Meeting 2012/13
--->[+]Gesundheitsökonomie
--->[+]Bildgebende Verfahren
--->[+]Juvenile HK
--->[+]Motorischer Phänotyp
--->[+]Neuroprotektive Therapie
--->[-]Physiotherapie
--->Termine
--->[-]Meetings
--->Meeting 2008/05
--->Meeting 2008/09
--->Meeting 2009
--->Meeting 2012
--->Meeting 2014
--->Meeting 2015
--->Meeting 2016
--->Call 2017 Subgroup Guide...
--->[+]Lebensqualität
--->[+]Behandlungstandards
--->[+]Chirurgische Ansätze
--->[+]Symptomatische Therapie
--->[-]Young Adults
--->[+]Dates
--->[-]Meetings
--->Meeting 2009/05
--->Meeting 2009/11
--->Meeting 2010/09
--->Members
[-]Veranstaltungen
--->[+]EHDN 2016
--->EHDN 2014
--->[-]EHDN 2012
--->Introduction
--->Announcement
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Important Dates
--->Registration
--->[+]Travel & Accommodation
--->[+]EHA Registration
--->EHA Programme
--->Reception Dinner
--->About Stockholm
--->[+]Abstract Submission
--->Reimbursement
--->[-]Documents
--->Handouts
--->Presentations
--->[-]Posters
--->Pathogenic mechanisms
--->Animal models
--->Choreatic disorders - no...
--->Genetic modifiers
--->Wet Biomarkers
--->Imaging
--->Clin characteristics
--->Clin char-motor
--->Clin char-cognitive
--->Clin char - behaviour
--->Clin char-other
--->Clinical studies
--->Genetic testing
--->Clinical care
--->Experimental Rx
--->Clinical Rx
--->Non-scientific
--->Contacts
--->Feedback & Evaluation
--->[+]EHDN 2010
--->[+]EHDN 2008
--->[+]EHDN 2007
--->[+]EHDN 2006
--->[+]EHDN 2005
--->[+]EHDN 2004
[-]Kommunikation
--->Kontakt
--->Chat
--->Mailinglisten - Öffentlich
--->Newsletter
--->Stellenangebote
DatumBeschreibungGrößeAutor Dokument 
03.08.26Selisistat: potential pharmacodynamic readouts based on transcriptomics32 kBanonymousapplication/mswordf04-potential-pharmacodynamic-readouts 
03.08.26Mutant Huntingtin fragmentation in immune cells tracks Huntington’s Disease progression32 kBanonymousapplication/mswordf05-mutant-huntingtin-fragmentation 
03.08.26Whole blood SAGE digital gene expression profiling from Huntington's disease patients32 kBanonymousapplication/mswordf03-blood-sage-digital-gene-expression 
03.08.26Selisistat: Soluble htt protein levels as a potential pharmacodynamic readout32 kBanonymousapplication/mswordf02-soluble-htt-protein-levels 
03.08.26Establishment of novel assays for quantification of full-length wild-type and mutant Huntingtin by using the AlphaLISA technology32 kBanonymousapplication/mswordf01-establishment-novel-assays 
03.08.26A critical evaluation of inflammatory markers in Huntington’s Disease plasma32 kBanonymousapplication/mswordf06-critical-evaluation-inflammatory-m... 
03.08.26Cross-sectional and longitudinal associations between CRP and neuropsychiatric symptoms in HD32 kBanonymousapplication/mswordf07-crp-neuropsychiatric-symptoms 
03.08.26Abnormal regulation of macrophage-derived transforming growth factor – β 1 (TGF-β1) production in Huntington Disease32 kBanonymousapplication/mswordf12-abnormal-regulation-of-macrophage 
03.08.268OHdG is not a biomarker for Huntington’s Disease; lessons for future biomarker studies32 kBanonymousapplication/mswordf14-8ohdg 
03.08.26Progredient deterioration of hepatic mitochondrial function in Huntington's Disease – measured by using the 13C-methionin breath test32 kBanonymousapplication/mswordf11-progredient-deterioration-hepatic-... 
03.08.26The study on molecular changes related to energy metabolism in Huntington’s disease subjects - looking for biomarkers32 kBanonymousapplication/mswordf09-molecular-changes-related-to-energ... 
03.08.26The autoimmune profile of Huntington`s Disease patients - a pilot study32 kBanonymousapplication/mswordf08-autoimmune-profile 
03.08.26A new biomarker in Huntington's disease32 kBanonymousapplication/mswordf15-new-biomarker 

Verzeichnis enthält 13 Dokumente.
impressum | datenschutz | haftungsausschluss | nutzungsbedingungen